Premium
F1‐02‐01: SUBTHRESHOLD AMYLOID ACCUMULATION: DOES IT PREDICT MEMORY DECLINE?
Author(s) -
Landau Susan M.
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.4373
Subject(s) - neurodegeneration , dementia , cognitive decline , biomarker , cognition , memory impairment , psychology , population , neuroscience , medicine , disease , biology , biochemistry , environmental health
perform content analyses for themes and correlations and summary analyses from quantitative survey items. Results: We will present participant reported availability of a study partner for preclinical AD trials and the frequency of positive and negative associations with the study partner requirement. We will explore potential covariate relationships with study outcomes, including overall willingness to enroll in a preclinical AD trial. Conclusions: This study will provide critical insight to why the study partner requirement is a barrier to enrollment in preclinical AD trials. Our data will instruct how to reduce barriers to recruitment and inform potential ethical challenges related to the requirement of dyadic enrollment.